comparemela.com

Latest Breaking News On - Biotrack capital - Page 3 : comparemela.com

Asia-Pacific s medical devices industry top deal activity in June 2022

Total deals worth $755.9m were announced in Asia-Pacific's medical devices industry deal activity during June 2022 compared to last 12 months: GlobalData

United statesUnited kingdomCreador sdnWarburg pincusAccumax lab technologyLife science fundShanghai equity investment fundAstrazeneca zhongjin medical industry fundBoston scientificCustom mounting solutions for healthcare applicationsFund managementIndia life sciences fundB capital groupYunfeng fundCambridge capital groupMerchants investment management

NuProbe Closes $50M Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesDavid zhangYingshuang chaiLife science fundNuprobe globalScience fundSequoia capital chinaBiotrack capitalYonghua capitalPappas capitalHaoreng capitalDeguan capitalNuprobe united states

NuProbe Closes $50M in New Fundraising

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesYi zhouDavid zhangYuhui liYingshuang chaiBing chenRibo bioJunbao shanJin liNature communicationsLife science fundNucleic acids researchRachel reed nuprobe united states incChina resources groupBusiness development at astrazenecaResearch use

NuProbe Global Raises $50M

The genomics and molecular diagnostics firm, which is based in the US and China, had raised $42 million in early 2021.

United statesYingshuang chaiLife science fundNuprobe globalScience fundPanlin capitalSequoia capital chinaBiotrack capitalPappas capitalHaoreng capitalProbe cofounderBionano genomics

Cargene Biopharma Raises US$19 2M in Pre-A Funding Round

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesRoger fooKausik rayTorsten wuestefeldHarvey lodishCargene biopharmaAgency for scienceGenome instituteBiotrack capitalHyfinity investmentsYann chong tan

vimarsana © 2020. All Rights Reserved.